Medical experts say there are at least 14 lesser-known symptoms of lung cancer people can look out for. Many are very rare, ...

Lung cancer is one of the most common and serious types of cancer with around 47,000 people diagnosed with the condition ...

奥希替尼是一种三代表皮生长因子（Epidermal Growth Factor Receptor, EGFR）酪氨酸激酶抑制剂（Tyrosine Kinase Inhibitor, TKI），目前是携带 EGFR ...

Research provides a foundation for further exploration of NK cells for the development of future treatments and therapies for ...

该研究利用单细胞测序技术，对 肺癌 脑转移样本进行了深入分析，揭示了TKI靶向药物奥希替尼在治疗过程中的耐药机制。奥希替尼不仅能够显著提升T细胞在肿瘤中的浸润度，还促使 免疫 检查点CTLA4的表达上调。这种机制的出现最终导致了 肿瘤细胞 ...

A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their ...

Trinity College Dublin researchers, based at St James’s Hospital have provided important insights into the behaviour and metabolic function of a previously largely unknown, but crucial ‘natural killer ...

Photodynamic therapy: Doctors use light to kill cancer cells and shrink tumors. Stent: Lung tumors that have grown into an airway can cause trouble breathing or other problems. Your doctor puts a ...

About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms ...

Anchor] In the future, it is expected that it will be possible to develop an mRNA vaccine that is sucked into the respiratory ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...